Unknown

Dataset Information

Significance of chemotherapy-free interval and tumor regression grade in patients with recurrent esophageal squamous cell carcinoma receiving chemotherapy with fluorouracil and platinum after esophagectomy following preoperative chemotherapy.


ABSTRACT:

Background

In Japan, standard treatment for locally advanced esophageal squamous cell carcinoma (ESCC) includes preoperative chemotherapy with fluorouracil plus cisplatin followed by esophagectomy. However, its efficacy is unclear in patients with recurrent disease with < 6 months of chemotherapy-free interval (CFI) after preoperative chemotherapy followed by esophagectomy and in those with ≥ 6 months of CFI and poor pathological response to prior preoperative chemotherapy.

Method

We retrospectively evaluated the efficacy of fluorouracil plus platinum in patients with recurrent ESCC who received preoperative chemotherapy followed by curative esophagectomy.

Results

Among 105 patients with recurrent ESCC after preoperative chemotherapy followed by esophagectomy, a total

SUBMITTER: Okunaka M 

PROVIDER: S-EPMC8921032 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature